Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

✍ Scribed by H. Goldschmidt; P. Sonneveld; F.W. Cremer; B. Holt; P. Westveer; I. Breitkreutz; A. Benner; A. Glasmacher; I.G.D. Schmidt-Wolf; H. Martin; D. Hoelzer; A.D. Ho; H.M. Lokhorst

• Publisher: Springer
• Year: 2003
• Tongue: English
• Weight: 138 KB
• Volume: 82
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-003-0685-2